Even the current members of the Supreme Court might find a federal court’s attempt to undercut FDA’s congressionally approved authority “too much,” says Dean Rachel Rebouche.
Published on May 3, 2023
Abortion Pill Fight at SCOTUS May Be ‘Boundary Testing’
